Ian M. Adcock
- Physiology top 0.02%
- Asthma and respiratory diseases 216
- Immunology top 0.1%
- IL-33, ST2, and ILC Pathways 57
- Immune Response and Inflammation 48
- Pulmonary and Respiratory Medicine top 0.02%
- Chronic Obstructive Pulmonary Disease (COPD) Research 134
- Neonatal Respiratory Health Research 53
- Emergency Medical Services top 0.02%
- Pediatric health and respiratory diseases 49
- Cancer Research top 0.2%
- NF-κB Signaling Pathways 52
-
- Histone Deacetylase Inhibitors Research 43
- Co-authors
- Peter J. BarnesKian Fan ChungKazuhiro ItoGaetano CaramoriBorja G. CosíoIrfan RahmanAndrew DurhamElen Jazrawi
- Journals
- New England Journal of Medicine (1 paper)Proceedings of the National Academy of Sciences (1 paper)The Lancet (3 papers)
- Partner nations
- United KingdomUnited StatesNetherlands
In The Last Decade
Ian M. Adcock
627 papers receiving 35.5k citations
Hit Papers
Peers
Comparison fields: 5 of 184
- Physiology 13.1k
- Immunology 8.6k
- Pulmonary and Respiratory Medicine 12.6k
- Emergency Medical Services 2.7k
- Cancer Research 3.9k
Countries citing papers authored by Ian M. Adcock
This map shows the geographic impact of Ian M. Adcock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian M. Adcock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian M. Adcock more than expected).
Fields of papers citing papers by Ian M. Adcock
This network shows the impact of papers produced by Ian M. Adcock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian M. Adcock. The network helps show where Ian M. Adcock may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ian M. Adcock, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 4 | |
| 2 | 2024 | 7 | |
| 3 | 2024 | 2 | |
| 4 | 2023 | 4 | |
| 5 | 2023 | 4 | |
| 6 | 2023 | 15 | |
| 7 | 2023 | 15 | |
| 8 | 2021 | 6 | |
| 9 | 2020 | 6 | |
| 10 | 2019 | 11 | |
| 11 | 2018 | 15 | |
| 12 | 2017 | 66 | |
| 13 | The roles of T helper 1, T helper 17 and regulatory T cells in the pathogenesis of sarcoidosis | 2016 | 14 |
| 14 | Immunopathology of Sarcoidosis | 2014 | 3 |
| 15 | 2014 | 98 | |
| 16 | 2013 | 73 | |
| 17 | 2013 | 1 | |
| 18 | LPS induced inflammatory responses in human peripheral blood mononuclear cells is mediated through NOX4 and G(i)alpha dependent PI-3kinase signalling | 2012 | 6 |
| 19 | 2005 | 43 | |
| 20 | 2002 | 386 |
About Ian M. Adcock
Ian M. Adcock is a scholar working on Physiology, Immunology and Pulmonary and Respiratory Medicine, having authored 645 papers that have together received 36.4k indexed citations. Recurring topics across this work include Asthma and respiratory diseases (216 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (134 papers), IL-33, ST2, and ILC Pathways (57 papers), Neonatal Respiratory Health Research (53 papers), NF-κB Signaling Pathways (52 papers), Pediatric health and respiratory diseases (49 papers), Immune Response and Inflammation (48 papers) and Histone Deacetylase Inhibitors Research (43 papers). The work is most often cited by research in Physiology (13.1k citations), Immunology (8.6k citations) and Pulmonary and Respiratory Medicine (12.6k citations). Ian M. Adcock has collaborated with scholars based in United Kingdom, United States and Netherlands. Frequent co-authors include Peter J. Barnes, Kian Fan Chung, Kazuhiro Ito, Gaetano Caramori, Borja G. Cosío, Irfan Rahman, Andrew Durham, Elen Jazrawi, Sharon Mumby and Robert Newton. Their work appears in journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.